This study aims to evaluate the adherence of patients to combined treatment with bisphosphonates and calcium and vitamin D supplements, which is one of the usual treatments for postmenopausal osteoporosis. The study will consist of a single visit that will coincide with one of the patient's usual follow-up visits according to standard clinical practice. During this visit, information will be collected from the patient's medical history and an interview will be conducted using 3 questionnaires to assess how and how often the patient takes the treatment, possible forgetfulness, and whether or not the patient is satisfied with their current treatment.
Study Type
OBSERVATIONAL
Enrollment
480
Clinica Gaias Santiago
Santiago de Compostela, A coruña, Spain
RECRUITINGCP Dr Caracuel
Córdoba, Andalusia, Spain
RECRUITINGHospital Reina Sofia
Córdoba, Andalusia, Spain
RECRUITINGHospital Virgen del Rocio
Seville, Andalusia, Spain
RECRUITINGCP Dr Agramonte
Palma de Mallorca, Balearic Islands, Spain
RECRUITINGCP Dr Balta
Palma de Mallorca, Balearic Islands, Spain
RECRUITINGCHU Insular - H Materno-Infantil
Las Palmas de Gran Canaria, Canary Islands, Spain
RECRUITINGCHU Insular - H Materno-Infantil
Las Palmas de Gran Canaria, Canary Islands, Spain
RECRUITINGHospital Zamora
Zamora, Castille and León, Spain
RECRUITINGClinica Sagrada Familia
Barcelona, Catalonia, Spain
RECRUITING...and 11 more locations
Intergroup adherence
To evaluate intergroup adherence to the most common oral regimens used in the treatment of postmenopausal OP that combine BP and Ca/D supplements, using a 8-items Morisky Medication Adherence Scale
Time frame: Day 1
Persistence intergroup
To evaluate, intergroup, the persistence to the most common oral regimens used in the treatment of postmenopausal OP that combine BP and Ca/D supplements. It will be evaluated over time from the start of the combination of both until the first end date of administration of either one, and by the percentage of patients who continue with the combined treatment since its prescription
Time frame: Day 1
Adherence intragroup
To evaluate, intragroup, the adherence to the prescribed usual oral regimens, using a 8-items Morisky Medication Adherence Scale
Time frame: Day 1
Persistence intragroup
To evaluate, intragroup, the persistence to the prescribed usual oral regimens.
Time frame: Day 1
Factors of non-adherence
To evaluate possible determining factors of non-adherence to the prescribed usual oral regimens and their comparison between the different regimens.
Time frame: Day 1
Factors of non-persistence
To evaluate possible determining factors of non-persistence to the prescribed usual oral regimens and their comparison between different regimens.
Time frame: Day 1
Treatment satisfaction
To evaluate the patient's satisfaction with the combined treatment received using a Likert scale.
Time frame: Day 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.